Our data form a cohort with 194 NSCLC cases, however, showed strong correlations of TG2 expression with DFS and with OS in overall NSCLC patients diagnosed with both non-adenocarcinoma subtype and adenocarcinoma subtype of cancers. This evidence concerns the gene TGM2 and non-small cell lung carcinoma.